SRTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Sensus Healthcare, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$2.76−0.01 (-0.36%)
Close on Oct 19, 2026
- Market cap
- $45.44M
- P/E (TTM)
- –
- Dividend yield
- –
Sensus Healthcare, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $19.76M | $36.40M | $20.35M | $40.01M | $5.45M | $25.11M | $24.65M | $19.00M | 71.9% | -45.7% |
| Service Revenue [Member] | $3.46M | $3.20M | $2.80M | $3.17M | – | – | – | – | 12.6% | +8.1% |
| Service [Member] | $2.54M | $1.96M | $1.26M | $1.35M | $4.13M | $2.15M | $1.78M | $1.58M | 9.2% | +29.6% |
| Product Revenue [Member] | $1.72M | $247.00K | – | – | – | – | – | – | 6.3% | +596.8% |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| United States | $25.36M | $40.18M | $22.28M | $41.98M | – | – | – | – | 92.3% | -36.9% |
| China | $2.03M | $1.45M | $1.49M | $2.45M | – | – | – | – | 7.4% | +40.5% |
| Other [Member] | $90.00K | $182.00K | $2.00K | $104.00K | – | – | – | – | 0.3% | -50.5% |
| Ireland | – | $0 | $135.00K | – | – | – | – | – | – | – |
| Guatemala | – | $0 | $190.00K | – | – | – | – | – | – | – |
| Türkiye | – | $0 | $265.00K | – | – | – | – | – | – | – |
| Israel | – | $172.00K | $43.00K | – | – | – | – | – | – | – |
From the segment and revenue-disaggregation notes of Sensus Healthcare's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.